Aldeyra Therapeutics Inc.
ALDX
|
|
| |
|
| Trading Volume | 4,616 |
|
|
7.57 - 1.47 |
| Market Cap Full | $ 200.6M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 8.9% | -7% | 42.7% | 11.1% |
| Q2 | - | 4.1% | -15.5% | -10.2% |
| Q3 | - | -38.2% | -20.4% | 33.8% |
| Q4 | - | -9.3% | -42.1% | 30.3% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.9 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -10.8 | 15.7 | -9.8 | 18.2 | 0.3 | -11.9 | - | - | - | - | - | 1.9 |
| 2023 | |||||||||||
| -15.2 | 14.6 | 46.9 | -4 | -0.4 | -11.6 | -3.3 | -8.1 | -10.5 | -74.4 | 62 | 26.7 |
| 2022 | |||||||||||
| -8.3 | 10.1 | 10 | -30.9 | 0.3 | 29.6 | 26.3 | 39.7 | -24.2 | 2.3 | 2.6 | 24.3 |
| 2021 | |||||||||||
| 65.4 | 9.5 | -6.4 | 9.6 | -0.4 | -9.5 | -21.5 | 6.6 | -7.1 | 3.2 | -17.7 | -46.6 |
| 2020 | |||||||||||
| -10 | -31 | -32.7 | 27.5 | 56.2 | -15.2 | 54.2 | 2.6 | 12.3 | -14.6 | 11.1 | -3.7 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.3 | -0.3 | -0.3 | -0.3 |
| Q2 | -0.2 | -0.3 | -0.3 | -0.3 |
| Q3 | -0.1 | -0.3 | -0.3 | -0.2 |
| Q4 | 0 | -0.2 | -0.3 | -0.3 |
| A | -0.56 | -1.1 | -1.1 | -1.1 |